Director Dealing

RNS Number : 4939Z

Physiomics PLC

21 May 2021

 

21 May 2021

Physiomics plc

("Physiomics") or ("the Company")

Director Dealing

The Company announces that Dr Jim Millen, Chief Executive Officer of Physiomics, has transferred, for no consideration, 242,287 ordinary shares of 0.4p each in the Company ("Ordinary Shares") from a brokerage account with James Brearley & Sons Limited to an account with Interactive Investors.  The Ordinary Shares remain beneficially owned by Dr Millen.

Dr Millen's holding in the Company therefore remains 1,384,393 Ordinary Shares, representing approximately 1.42 per cent. of the Company's issued share capital.

Enquiries:

Physiomics plc 

Dr Jim Millen, CEO

[phone]

Hybridan LLP (broker)

Claire Louise Noyce

[phone]

Strand Hanson Ltd (NOMAD)

James Dance & James Bellman

[phone]

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	James Millen
2	Reason for the notification
a)	Position/status	Director, CEO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Physiomics plc
b)	LEI	213800A71DSZ6ABMTQ91
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary share GB00BDR6W943
b)	Nature of the transaction	Transfer of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) Nil 242,287
d)	Aggregated information -  Aggregated volume -  Price	242,287 Nil
e)	Date of the transaction	21 May 2021
f)	Place of the transaction	XLON, AIM

 

END

 

 

DSHABMATMTJTBTB